Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Journal of Medical Research
Published in: European Journal of Medical Research 1/2023

Open Access 01-12-2023 | Non-Invasive Ventilation | Review

The efficacy of high-flow nasal cannula (HFNC) versus non-invasive ventilation (NIV) in patients at high risk of extubation failure: a systematic review and meta-analysis

Authors: Qiaoying Wang, Yanchun Peng, Shurong Xu, Lingyu Lin, Liangwan Chen, Yanjuan Lin

Published in: European Journal of Medical Research | Issue 1/2023

Login to get access

Abstract

Background

Studies suggest that high-flow nasal cannula (HFNC) and non-invasive ventilation (NIV) can prevent reintubation in critically ill patients with a low risk of extubation failure. However, the safety and effectiveness in patients at high risk of extubation failure are still debated. Therefore, we conducted a systematic review and meta-analysis to compare the efficacies of HFNC and NIV in high-risk patients.

Methods

We searched eight databases (MEDLINE, Cochrane Library, EMBASE, CINAHL Complete, Web of Science, China National Knowledge Infrastructure, Wan-Fang Database, and Chinese Biological Medical Database) with reintubation as a primary outcome measure. The secondary outcomes included mortality, intensive care unit (ICU) length of stay (LOS), incidence of adverse events, and respiratory function indices. Statistical data analysis was performed using RevMan software.

Results

Thirteen randomized clinical trials (RCTs) with 1457 patients were included. The HFNC and NIV groups showed no differences in reintubation (RR 1.10, 95% CI 0.87–1.40, I2 = 0%, P = 0.42), mortality (RR 1.09, 95% CI 0.82–1.46, I2 = 0%, P = 0.54), and respiratory function indices (partial pressure of carbon dioxide [PaCO2]: MD − 1.31, 95% CI − 2.76–0.13, I2 = 81%, P = 0.07; oxygenation index [P/F]: MD − 2.18, 95% CI − 8.49–4.13, I2 = 57%, P = 0.50; respiratory rate [Rr]: MD − 0.50, 95% CI − 1.88–0.88, I2 = 80%, P = 0.47). However, HFNC reduced adverse events (abdominal distension: RR 0.09, 95% CI 0.04–0.24, I2 = 0%, P < 0.01; aspiration: RR 0.30, 95% CI 0.09–1.07, I2 = 0%, P = 0.06; facial injury: RR 0.27, 95% CI 0.09–0.88, I2 = 0%, P = 0.03; delirium: RR 0.30, 95%CI 0.07–1.39, I2 = 0%, P = 0.12; pulmonary complications: RR 0.67, 95% CI 0.46–0.99, I2 = 0%, P = 0.05; intolerance: RR 0.22, 95% CI 0.08–0.57, I2 = 0%, P < 0.01) and may have shortened LOS (MD − 1.03, 95% CI − 1.86–− 0.20, I2 = 93%, P = 0.02). Subgroup analysis by language, extubation method, NIV parameter settings, and HFNC flow rate revealed higher heterogeneity in LOS, PaCO2, and Rr.

Conclusions

In adult patients at a high risk of extubation failure, HFNC reduced the incidence of adverse events but did not affect reintubation and mortality. Consequently, whether or not HFNC can reduce LOS and improve respiratory function remains inconclusive.
Appendix
Available only for authorised users
Literature
1.
Wunsch H, Wagner J, Herlim M, Chong DH, Kramer AA, Halpern SD. ICU occupancy and mechanical ventilator use in the United States. Crit Care Med. 2013;41(12):2712–9.PubMedCrossRef
2.
Miltiades AN, Gershengorn HB, Hua M, Kramer AA, Li G, Wunsch H. Cumulative probability and time to reintubation in U.S. ICUs. Crit Care Med. 2017;45(5):835–42.PubMedPubMedCentralCrossRef
3.
Jolley SE, Moss M, Needham DM, Caldwell E, Morris PE, Miller RR, et al. Point prevalence study of mobilization practices for acute respiratory failure patients in the United States. Crit Care Med. 2017;45(2):205–15.PubMedPubMedCentralCrossRef
4.
Esteban A, Anzueto A, Alía I, Gordo F, Apezteguía C, Pálizas F, et al. How is mechanical ventilation employed in the intensive care unit? An international utilization review. Am J Respir Crit Care Med. 2000;161(5):1450–8.PubMedCrossRef
5.
6.
Thille AW, Richard JC, Brochard L. The decision to extubate in the intensive care unit. Am J Respir Crit Care Med. 2013;187(12):1294–302.PubMedCrossRef
7.
Frutos-Vivar F, Esteban A, Apezteguia C, González M, Arabi Y, Restrepo MI, et al. Outcome of reintubated patients after scheduled extubation. J Crit Care. 2011;26(5):502–9.PubMedCrossRef
8.
Thille AW, Harrois A, Schortgen F, Brun-Buisson C, Brochard L. Outcomes of extubation failure in medical intensive care unit patients. Crit Care Med. 2011;39(12):2612–8.PubMedCrossRef
9.
Nava S, Gregoretti C, Fanfulla F, Squadrone E, Grassi M, Carlucci A, et al. Noninvasive ventilation to prevent respiratory failure after extubation in high-risk patients. Crit Care Med. 2005;33(11):2465–70.PubMedCrossRef
10.
Ferrer M, Valencia M, Nicolas JM, Bernadich O, Badia JR, Torres A. Early noninvasive ventilation averts extubation failure in patients at risk: a randomized trial. Am J Respir Crit Care Med. 2006;173(2):164–70.PubMedCrossRef
11.
Smith TA, Davidson PM, Jenkins CR, Ingham JM. Life behind the mask: the patient experience of NIV. Lancet Respir Med. 2015;3(1):8–10.PubMedCrossRef
12.
Spicuzza L, Schisano M. High-flow nasal cannula oxygen therapy as an emerging option for respiratory failure: the present and the future. Ther Adv Chronic Dis. 2020;11:2040622320920106.PubMedPubMedCentralCrossRef
13.
Hernández G, Vaquero C, Colinas L, Cuena R, González P, Canabal A, et al. Effect of Postextubation high-flow nasal cannula vs Noninvasive ventilation on reintubation and Postextubation respiratory failure in high-risk patients: a randomized clinical trial. JAMA. 2016;316(15):1565–74.PubMedCrossRef
14.
Longhini F, Pisani L, Lungu R, Comellini V, Bruni A, Garofalo E, et al. High-flow oxygen therapy after noninvasive ventilation interruption in patients recovering from hypercapnic acute respiratory failure: a physiological crossover trial. Crit Care Med. 2019;47(6):e506–11.PubMedCrossRef
15.
Tan D, Walline JH, Ling B, Xu Y, Sun J, Wang B, et al. High-flow nasal cannula oxygen therapy versus non-invasive ventilation for chronic obstructive pulmonary disease patients after extubation: a multicenter, randomized controlled trial. Crit Care. 2020;24(1):489.PubMedPubMedCentralCrossRef
16.
17.
Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1.PubMedPubMedCentralCrossRef
18.
Coplin WM, Pierson DJ, Cooley KD, Newell DW, Rubenfeld GD. Implications of extubation delay in brain-injured patients meeting standard weaning criteria. Am J Respir Crit Care Med. 2000;161(5):1530–6.PubMedCrossRef
19.
De Jong A, Wrigge H, Hedenstierna G, Gattinoni L, Chiumello D, Frat JP, et al. How to ventilate obese patients in the ICU. Intensive Care Med. 2020;46(12):2423–35.PubMedPubMedCentralCrossRef
20.
Vallverdú I, Calaf N, Subirana M, Net A, Benito S, Mancebo J. Clinical characteristics, respiratory functional parameters, and outcome of a two-hour T-piece trial in patients weaning from mechanical ventilation. Am J Respir Crit Care Med. 1998;158(6):1855–62.PubMedCrossRef
21.
Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.PubMedPubMedCentralCrossRef
22.
Yang Y, Liu N, Hou X, Sun L, Wang H, Jin Q. Effects of high-flow nasal cannula and noninvasive positive pressure ventilation for the hypoxemia following cardiac surgery. J Cap Med Univ. 2016;37(05):664–71.
23.
Zhang J, Wu F, Meng L, Zeng C, lu Y. A study on the effects and safety of sequential humidified high flow nasal cannula oxygenation therapy on the COPD patients after extubation. Natl Med J China. 2018;98(02):109–12.
24.
Hu S, Tang H, Fan X. Therapeutic efficacy of high-flow nasal cannula and noninvasive positive-pressure ventilation in AECOPD patients with various APACHE II scores after extubation. Chin Gen Pract. 2018;21(15):1790–5.
25.
Liu J, Yang S, Yuan J, Yang W, Meng S, Liu J, et al. Clinical study of sequential nasal high-flow oxygen therapy in mechanically ventilated patients with chronic obstructive pulmonary disease. Chin J Emerg Med. 2019;04:459–62.
26.
Yu J, Zhang R, Zhu J, Liu H, Chen Q, Shao J. Clinical efficacy of sequential therapy from invasive ventilator to high-flow nasal cannula oxygen therapy of patients with acute exacerbations of chronic obstructive pulmonary disease. Chin J Crit Care Intensive Care Med. 2019;5(03):213–8.
27.
Jing G, Li J, Hao D, Wang T, Sun Y, Tian H, et al. Comparison of high flow nasal cannula with noninvasive ventilation in chronic obstructive pulmonary disease patients with hypercapnia in preventing postextubation respiratory failure: a pilot randomized controlled trial. Res Nurs Health. 2019;42(3):217–25.PubMedCrossRef
28.
Yu Z, Zhang R, Huang H, Lee J, Geng S. Efficacy and safety of humidified high flow nasal cannula in chronic obstructive pulmonary disease complicated with type 2 respiratory failure patients after extubation:a randomized controlled trial. Acad J Naval Med Univ. 2019;40(09):989–94.
29.
Wang J, Meng L, Yan S. Sequential high-flow nasal cannula oxygen therapy after extubation for 30 patients with severe acute pancreatitis and acute respiratory distress syndrome. Chin J Crit Care Intensive Care Med. 2021;14(02):142–5.
30.
Shang X, Wang Y. Comparison of outcomes of high-flow nasal cannula and noninvasive positive-pressure ventilation in patients with hypoxemia and various APACHE II scores after extubation. Ther Adv Respir Dis. 2021;15:17534666211004236.PubMedPubMedCentralCrossRef
31.
Tongyoo S, Tantibundit P, Daorattanachai K, Viarasilpa T, Permpikul C, Udompanturak S. High-flow nasal oxygen cannula vs. noninvasive mechanical ventilation to prevent reintubation in sepsis: a randomized controlled trial. Ann Intensive Care. 2021;11(1):135.PubMedPubMedCentralCrossRef
32.
Xu S, Liu X. Sequential treatment of chronic obstructive pulmonary disease concurrent with respiratory failure by high-flow nasal cannula therapy. Am J Transl Res. 2021;13(4):2831–9.PubMedPubMedCentral
33.
34.
Nishimura M. High-flow nasal cannula oxygen therapy in adults: physiological benefits, indication, clinical benefits, and adverse effects. Respir Care. 2016;61(4):529–41.PubMedCrossRef
35.
Ricard JD, Roca O, Lemiale V, Corley A, Braunlich J, Jones P, et al. Use of nasal high flow oxygen during acute respiratory failure. Intensive Care Med. 2020;46(12):2238–47.PubMedPubMedCentralCrossRef
36.
Zhou X, Yao S, Dong P, Chen B, Xu Z, Wang H. Preventive use of respiratory support after scheduled extubation in critically ill medical patients-a network meta-analysis of randomized controlled trials. Crit Care. 2020;24(1):370.PubMedPubMedCentralCrossRef
37.
Thille AW, Muller G, Gacouin A, Coudroy R, Decavèle M, Sonneville R, et al. Effect of postextubation high-flow nasal oxygen with noninvasive ventilation vs high-flow nasal oxygen alone on reintubation among patients at high risk of extubation failure: a randomized clinical trial. JAMA. 2019;322(15):1465–75.PubMedPubMedCentralCrossRef
38.
Chang CJ, Chiang LL, Chen KY, Feng PH, Su CL, Hsu HS. High-flow nasal cannula versus noninvasive positive pressure ventilation in patients with heart failure after extubation: an observational cohort study. Can Respir J. 2020;2020:6736475.PubMedPubMedCentralCrossRef
39.
Stéphan F, Barrucand B, Petit P, Rézaiguia-Delclaux S, Médard A, Delannoy B, et al. High-flow nasal oxygen vs noninvasive positive airway pressure in hypoxemic patients after cardiothoracic surgery: a randomized clinical trial. JAMA. 2015;313(23):2331–9.PubMedCrossRef
40.
Roca O, Pérez-Terán P, Masclans JR, Pérez L, Galve E, Evangelista A, et al. Patients with New York Heart Association class III heart failure may benefit with high flow nasal cannula supportive therapy: high flow nasal cannula in heart failure. J Crit Care. 2013;28(5):741–6.PubMedCrossRef
41.
Parke RL, Bloch A, McGuinness SP. Effect of very-high-flow nasal therapy on airway pressure and end-expiratory lung impedance in healthy volunteers. Respir Care. 2015;60(10):1397–403.PubMedPubMedCentralCrossRef
42.
Mauri T, Turrini C, Eronia N, Grasselli G, Volta CA, Bellani G, et al. physiologic effects of high-flow nasal cannula in acute hypoxemic respiratory failure. Am J Respir Crit Care Med. 2017;195(9):1207–15.PubMedCrossRef
43.
Lee JH, Rehder KJ, Williford L, Cheifetz IM, Turner DA. Use of high flow nasal cannula in critically ill infants, children, and adults: a critical review of the literature. Intensive Care Med. 2013;39(2):247–57.PubMedCrossRef
44.
Roca O, Hernández G, Díaz-Lobato S, Carratalá JM, Gutiérrez RM, Masclans JR. Current evidence for the effectiveness of heated and humidified high flow nasal cannula supportive therapy in adult patients with respiratory failure. Crit Care. 2016;20(1):109.PubMedPubMedCentralCrossRef
45.
Thille AW, Coudroy R, Nay MA, Gacouin A, Decavèle M, Sonneville R, et al. Non-invasive ventilation alternating with high-flow nasal oxygen versus high-flow nasal oxygen alone after extubation in COPD patients: a post hoc analysis of a randomized controlled trial. Ann Intensive Care. 2021;11(1):30.PubMedPubMedCentralCrossRef
Metadata
Title
The efficacy of high-flow nasal cannula (HFNC) versus non-invasive ventilation (NIV) in patients at high risk of extubation failure: a systematic review and meta-analysis
Authors
Qiaoying Wang
Yanchun Peng
Shurong Xu
Lingyu Lin
Liangwan Chen
Yanjuan Lin
Publication date
01-12-2023
Publisher
BioMed Central
Published in
European Journal of Medical Research / Issue 1/2023
Electronic ISSN: 2047-783X
DOI
https://doi.org/10.1186/s40001-023-01076-9

Other articles of this Issue 1/2023

European Journal of Medical Research 1/2023 Go to the issue

Research

Luteolin inhibits A549 cells proliferation and migration by down-regulating androgen receptors

Research

Study on anxiety and depression in elderly patients with malignant liver tumor undergoing hepatectomy

Research

Analysis of the differential expression and prognostic relationship of DEGs in AML based on TCGA database

Research

Relationship between neutrophil to lymphocyte ratio and diabetic peripheral neuropathy: a systematic review and meta-analysis

Research

Effect of postoperative utilization of somatostatin on clinical outcome after definitive surgery for duodenal fistula

Research

Exploring the association between triglyceride-glucose index and thyroid function